Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.36 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | HRH1 | P35367 | 1/20 | 0.36 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.34 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2631146 | 1.00 | CA2 (0.41) | CA2MAPK1TSHRCHRM1ADRA1A | |
| SCHEMBL12891264 | 1.00 | CA2 (0.41) | CA2MAPK1TSHRCHRM1ADRA1A | |
| SCHEMBL4578586 | 0.81 | CA2 (0.39) | CA2MAPK1TSHRCHRM1ADRA1A | |
| SCHEMBL28651642 | 0.80 | SLC1A3 (0.36) | CA2MAPK1TSHRCHRM1ADRA1A | |
| SCHEMBL9519201 | 0.79 | CA2 (0.38) | CA2MAPK1TSHRCHRM1ADRA1A | |
| SCHEMBL17231916 | 0.79 | CHRM1 (0.50) | CA2MAPK1TSHRCHRM1ADRA1A | |
| SCHEMBL10925798 | 0.79 | CA2 (0.38) | CA2MAPK1TSHRCHRM1ADRA1A | |
| SCHEMBL15821811 | 0.79 | CA2 (0.38) | CA2MAPK1TSHRCHRM1ADRA1A | |
| SCHEMBL1966037 | 0.79 | CHRM1 (0.50) | CA2MAPK1TSHRCHRM1ADRA1A | |
| SCHEMBL28678611 | 0.79 | CA2 (0.38) | CA2MAPK1TSHRCHRM1ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3088955-B1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHINETSU CHEMICAL CO (JP) | 2020-06-03 | — | — | EP | claimed |
| EP-1747183-B1 | METHOD OF PREPARING ALKOXYLATION CATALYSTS AND THEIR USE IN ALKOXYLATION PROCESSES | HARCROS CHEMICALS INC (US) | 2018-06-06 | — | — | EP | claimed |
| EP-3032333-B1 | SHRINK MATERIAL AND PATTERN FORMING PROCESS | SHINETSU CHEMICAL CO (JP) | 2017-05-24 | — | — | EP | claimed |
| EP-3032332-B1 | SHRINK MATERIAL AND PATTERN FORMING PROCESS | SHINETSU CHEMICAL CO (JP) | 2017-04-05 | — | — | EP | claimed |
| EP-0522465-B1 | A process for the preparation of an alkyl vinyl ether/maleic anhydride copolymer | DAICEL CHEM (JP) | 1997-04-16 | — | — | EP | claimed |
| JP-57085348-A | — | — | None | — | — | JP | disclosed |
| US-11813306-B2 | Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders | NOVARTIS AG (CH) | 2023-11-14 | — | — | US | disclosed |
| US-20230272239-A1 | LIQUID COMPOSITION, LIQUID COMPOSITION FOR INKJET DISCHARGING, DEVICE FOR MANUFACTURING LAYER CONTAINING INORGANIC OXIDE, METHOD OF MANUFACTURING LAYER CONTAINING INORGANIC OXIDE, AND ELECTROCHEMICAL DEVICE | RICOH COMPANY, LTD. (JP) | 2023-08-31 | — | — | US | disclosed |
| EP-4235833-A1 | LIQUID COMPOSITION, LIQUID COMPOSITION FOR INKJET DISCHARGING, DEVICE FOR MANUFACTURING LAYER CONTAINING INORGANIC OXIDE, METHOD OF MANUFACTURING LAYER CONTAINING INORGANIC OXIDE, AND ELECTROCHEMICAL DEVICE | Ricoh Company, Ltd. (JP) | 2023-08-30 | — | — | EP | disclosed |
| CN-116615411-A | Process for producing peptide compound containing N-substituted amino acid residue | 中外制药株式会社 | 2023-08-18 | — | — | CN | disclosed |
| CN-115666494-A | Encapsulated compositions comprising core-shell microcapsules and methods of making the same | 奇华顿股份有限公司 | 2023-01-31 | — | — | CN | disclosed |
| CN-115297858-A | Pharmaceutical composition for treating hypertrophic cardiomyopathy and treatment method using same | 赛特瑞恩股份有限公司 | 2022-11-04 | — | — | CN | disclosed |
| EP-0833879-A1 | VAPOR PHASE COMBUSTION METHOD AND COMPOSITIONS II | ORR, William C. (US) | 1998-04-08 | — | — | EP | disclosed |
| EP-0763079-A1 | VAPOR PHASE COMBUSTION METHODS AND COMPOSITIONS | ORR, William C. (US) | 1997-03-19 | — | — | EP | disclosed |
| WO-1996040844-A1 | VAPOR PHASE COMBUSTION METHOD AND COMPOSITIONS II | ORR WILLIAM C (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1995033022-A1 | VAPOR PHASE COMBUSTION METHODS AND COMPOSITIONS | ORR WILLIAM C (US) | 1995-12-07 | — | — | WO | disclosed |
| US-5401604-A | Reaction product of polyepoxide, aromatic acid with phenolic hydroxy group, aromatic acid, quinone diazide with sulfonyl group, photoresists | NIPPON PAINT CO., LTD. (JP) | 1995-03-28 | — | — | US | disclosed |
| US-5374366-A | Branched alkyl di-, tri- and tetraesters; machine oil miscible with hydrofluoroalkane refrigerants; high viscosity index; low pour point; heat, weather and hydrolysis resistance | SANKEN CHEMICAL CO., LTD. (JP) | 1994-12-20 | — | — | US | disclosed |
| EP-0608894-A1 | Positive-type photosensitive resin compositions | Nippon Paint Co., Ltd. (JP) | 1994-08-03 | — | — | EP | disclosed |
| JP-S5785348-A | OPTICAL ACTIVE N-BENZYL ACETAMIDE DERIVATIVE, ITS PREPARATION, AND HERBICIDE CONTAINING IT AS ACTIVE INGREDIENT | SUMITOMO CHEM CO LTD | 1982-05-28 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11813306-B2 | Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders | PCSK9, PCSK7, PCSK6 | CA2 3259/4885MAPK1 1881/4885TSHR 589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.